-- title: "Avian Influenza A(H5N1) in Dairy Cattle: Diagnostic Challenges and One Health Implications" category: "livestock-viruses" metaDescription: "A technical review of HPAI H5N1 spillover into dairy cattle, covering molecular diagnostics, serology, viral stability in milk, and One Health surveillance frameworks." primaryKeyword: "H5N1 dairy cattle diagnostics" secondaryKeywords: ["avian influenza cattle", "H5N1 milk RT-qPCR", "bovine influenza serology", "One Health livestock", "HPAI biosecurity dairy"]
Avian Influenza A(H5N1) in Dairy Cattle: Diagnostic Challenges and One Health Implications
Introduction
The emergence of highly pathogenic avian influenza (HPAI) A(H5N1) clade 2.3.4.4b in dairy cattle represents a paradigm shift in the host range of influenza A viruses. Historically considered a pathogen of gallinaceous poultry and wild waterfowl, H5N1 has demonstrated an unprecedented capacity for mammalian adaptation, with sustained spillover events into US dairy herds beginning in late 2023 and continuing through subsequent lactation cycles [1, 7]. This event challenges long-held assumptions about the species barrier between avian influenza viruses and Bovidae, and it necessitates a re-evaluation of diagnostic algorithms, biosecurity protocols, and surveillance frameworks within the livestock sector.
This article provides a detailed examination of the virological, diagnostic, and epidemiological dimensions of H5N1 infection in dairy cattle. It focuses on molecular detection methods, serological profiling, viral stability in milk, and the computational modeling of within-herd transmission. The discussion is framed within a One Health context, emphasizing the interconnectedness of livestock health, wildlife ecology, and agricultural biosecurity.
Virological Basis of Spillover and Mammalian Adaptation
The H5N1 clade 2.3.4.4b viruses responsible for the bovine outbreaks possess a polybasic cleavage site in the hemagglutinin (HA) protein, a hallmark of high pathogenicity in avian species. However, the clinical presentation in cattle is markedly different from that in poultry. Infected dairy cows typically exhibit acute but transient clinical signs, including a sharp drop in milk production, changes in milk consistency (thickened, colostrum-like secretions), and mild to moderate pyrexia [3, 8]. Respiratory signs are generally absent, suggesting a tropism for mammary epithelial cells rather than the respiratory epithelium.
Molecular characterization of isolates from bovine milk has identified specific amino acid substitutions in the HA and neuraminidase (NA) proteins that may facilitate binding to mammalian-type sialic acid receptors. The preferential binding of avian influenza viruses to alpha-2,3-linked sialic acids, which are abundant in the avian intestinal tract and bovine mammary gland, provides a mechanistic basis for the observed tissue tropism [8]. Experimental inoculation studies have confirmed that a low infectious dose is sufficient to establish infection in lactating dairy cows, although transmission barriers exist that limit efficient cow-to-cow spread under standard housing conditions [3].
Diagnostic Challenges in Bovine H5N1 Detection
Molecular Detection: RT-qPCR and Sequencing
The primary diagnostic modality for H5N1 detection in dairy cattle is real-time reverse transcription polymerase chain reaction (RT-qPCR) targeting the matrix (M) gene or the H5 hemagglutinin gene. Milk and milk filter samples are the specimens of choice due to the high viral load shed into mammary secretions. Viral RNA concentrations in milk can exceed 10^6 genome copies per milliliter during the acute phase of infection, making milk a highly sensitive matrix for surveillance [9, 11].
However, significant challenges exist in assay standardization and sensitivity. An interlaboratory comparison study demonstrated method-dependent sensitivity variability across different RT-qPCR protocols [9]. Factors contributing to this variability include differences in primer-probe sets, reverse transcriptase enzymes, and RNA extraction efficiencies from the lipid-rich milk matrix. The presence of PCR inhibitors such as casein and free fatty acids can reduce amplification efficiency, necessitating the use of specialized extraction kits and internal amplification controls.
For confirmatory and molecular epidemiological purposes, next-generation sequencing (NGS) of full viral genomes from milk samples is recommended. Sequencing strategies employed during the emergency response have included both amplicon-based and metagenomic approaches, with the latter providing unbiased detection of co-infections or novel reassortants [12]. The high viral titers in milk facilitate whole-genome recovery, enabling phylogenetic tracking of viral lineages and the identification of mammalian adaptation markers.
Serological Testing
Serological detection of anti-H5 antibodies in cattle provides evidence of past infection and is critical for understanding the true prevalence of exposure within a herd. The hemagglutination inhibition (HI) assay, using a clade-matched H5 antigen, remains the gold standard for serotyping. However, the HI assay requires the removal of non-specific inhibitors from bovine serum, typically via receptor-destroying enzyme (RDE) treatment, which can introduce variability.
Enzyme-linked immunosorbent assays (ELISAs) for the detection of antibodies to avian influenza virus H5N1 have been developed and validated for bovine matrices. A longitudinal study demonstrated that naturally infected cattle maintain detectable antibody titers for more than a year post-infection, suggesting that serosurveillance can identify herds with historical exposure even after viral RNA is no longer detectable [1]. This finding has important implications for retrospective outbreak investigations and for certifying herds as free from infection.
Viral Stability in Milk
The stability of H5N1 in raw and pasteurized milk is a critical consideration for both diagnostic sample handling and food safety. Influenza viruses are enveloped and are generally susceptible to heat inactivation. However, studies have shown that H5N1 can remain infectious in raw milk stored at refrigeration temperatures for several weeks, and the virus is stable across a range of pH values typical of bovine milk [10]. Pasteurization at standard time-temperature combinations (e.g., 72 degrees Celsius for 15 seconds) effectively inactivates the virus, but the presence of high initial viral loads in bulk tank milk necessitates rigorous process control.
Clinical Presentation and Herd-Level Dynamics
The clinical syndrome in dairy cattle is characterized by an abrupt onset of anorexia, decreased rumen motility, and a dramatic reduction in milk yield. Affected cows produce milk that is thick, yellow, and resembles colostrum. The milk often tests positive for viral RNA by RT-qPCR for 2 to 4 weeks post-onset, although viral shedding can persist at low levels in individual animals for longer periods [11].
Within-herd transmission dynamics have been modeled using approximate Bayesian computation approaches, which estimate the basic reproduction number (R0) for H5N1 in dairy herds. Estimates suggest that R0 is below 1 under standard management conditions, indicating that sustained transmission is inefficient and that outbreaks are likely driven by repeated introductions from external sources rather than by rapid cow-to-cow spread [4]. This finding has direct implications for control strategies, emphasizing the importance of biosecurity over mass culling.
Biosecurity and Control Strategies
Biosecurity measures for dairy operations must be adapted to address the unique features of H5N1 epidemiology. Key interventions include:
- Restriction of movement of lactating cows between herds.
- Enhanced hygiene protocols for milking equipment, as fomite transmission via contaminated teat cups and milk lines is a plausible route of spread.
- Segregation of sick cows and dedicated milking order to reduce viral load in bulk tank milk.
- Monitoring of bulk tank milk by RT-qPCR at regular intervals to detect incursions early.
- Control of wild bird access to feed and water sources, as spillover from wild birds is the most likely initial source of infection [7, 8].
Vaccination of cattle against H5N1 is under investigation. Dual-route vaccination strategies, combining parenteral and mucosal administration, have been shown to induce both systemic and mucosal immunity in bovine models [15]. However, no licensed vaccine for H5N1 in cattle is currently available, and vaccine development must account for the rapid antigenic evolution of the virus.
One Health Implications
The spillover of H5N1 into dairy cattle has profound One Health implications. Cattle can serve as a bridging host, facilitating the adaptation of avian influenza viruses to mammalian hosts and potentially increasing the risk of zoonotic transmission. While human infections with H5N1 remain rare and are typically associated with direct contact with infected poultry, the high viral loads in bovine milk present a novel exposure pathway for dairy workers [13].
Computational modeling of multihost epidemic spread has been used to simulate the interconnected dynamics of livestock, wild birds, and human populations. These models incorporate data on animal movements, wild bird migration patterns, and human occupational exposure to predict the geographic spread of the virus and to identify high-risk interfaces [2]. The integration of diagnostic data from bulk tank milk surveillance into these models enhances their predictive power and supports real-time risk assessment.
The emergence of H5N1 in cattle also highlights the need for enhanced genomic surveillance across species. The Global Initiative on Sharing All Influenza Data (GISAID) and other sequence databases have been instrumental in tracking the evolution of clade 2.3.4.4b viruses. Phylogenetic analyses have revealed multiple independent spillover events from wild birds to cattle, as well as evidence of limited cow-to-cow transmission chains [7, 12].
Diagnostic Workflow for Bovine H5N1
The following Mermaid diagram illustrates a recommended diagnostic workflow for the detection and confirmation of H5N1 in dairy cattle, from sample collection to reporting.
flowchart TD
A[Clinical Suspicion: Drop in milk yield, thickened milk], > B[Collect Milk Sample]
B, > C{Matrix RT-qPCR for Influenza A}
C, >|Negative| D[No H5N1 detected. Consider other causes.]
C, >|Positive| E[Subtype-specific H5 RT-qPCR]
E, > F{Confirmatory Sequencing}
F, > G[Amplicon-based NGS or Metagenomic NGS]
G, > H[Phylogenetic Analysis & Clade Assignment]
H, > I[Report to Veterinary Authority]
I, > J[Implement Biosecurity Measures]
J, > K[Serosurveillance: HI Assay or ELISA]
K, > L[Long-term monitoring of antibody persistence]
Future Directions
The ongoing evolution of H5N1 clade 2.3.4.4b necessitates continuous refinement of diagnostic assays. The development of multiplex RT-qPCR panels that can simultaneously detect and differentiate H5, H7, and N1 subtypes would streamline laboratory workflows. Additionally, the application of CRISPR-based diagnostics offers the potential for rapid, field-deployable testing that does not require thermal cycling equipment.
From a computational biology perspective, machine learning algorithms trained on genomic and epidemiological data can predict which viral mutations are most likely to enhance mammalian adaptation or increase transmissibility. These predictive models can inform risk assessments and guide the allocation of surveillance resources.
Conclusion
The incursion of HPAI H5N1 into dairy cattle represents a significant event in influenza virology and livestock medicine. The diagnostic challenges posed by the milk matrix, the variability in RT-qPCR sensitivity, and the need for serological tools capable of detecting long-term antibody persistence require a coordinated laboratory response. The integration of molecular diagnostics, genomic surveillance, and computational modeling within a One Health framework is essential for understanding and mitigating the risks associated with this emerging pathogen. Continued investment in veterinary diagnostic infrastructure and cross-sectoral collaboration will be critical for safeguarding both animal and public health.
References
Shittu I, Rodriguez J, Oguzie JU et al. Detection of antibodies to avian influenza virus H5N1 clade 2.3.4.4b in naturally infected cattle for more than a year. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42209625/
Adiga A, Chopra A, Wilson ML et al. A high-resolution, US-scale digital similar of interacting livestock, wild birds, and human ecosystems for multihost epidemic spread. Proc Natl Acad Sci U S A. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42207910/
Lee C, Tarbuck NN, Cochran HJ et al. Dairy cows infected with influenza A(H5N1) reveals low infectious dose and transmission barriers. Nat Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42177170/
Malladi S, Carestia A, Seys SA et al. Estimating the Within-herd Transmission Rate of Highly Pathogenic Avian Influenza H5N1 Virus in a Dairy Herd using an Approximate Bayesian Computation Approach. J Dairy Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42155711/
Quirk GE, Vu MN, Le Sage V et al. Variable transmission efficiency of mammalian origin HPAI D1.1 H5N1 strains in ferrets. bioRxiv. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42146553/
Brown IH. The Gordon Memorial Lecture: A paradigm shift in high pathogenicity avian influenza and perspectives for the future. Br Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42145115/
Giacinti JA, Signore A, Torchetti M et al. North American perspective on the highly pathogenic avian influenza H5Nx clade 2.3.4.4b outbreak (November 2021 - March 2025). Can J Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42114152/
Ding K, Ding Y. H5N1 avian influenza in dairy cattle: Molecular adaptation, transmission mechanisms, and control strategies. Virology. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42107281/
Miller MR, Frost K, Smith EL et al. Evaluation of PCR-Based H5N1 Influenza Detection Methods in Milk from an Interlaboratory Comparison Study Demonstrating Method-Dependent Sensitivity Variability. J Food Prot. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42103287/
Schafers J, Warren CJ, Yang J et al. Stability of influenza viruses in the milk of cows and sheep. J Gen Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42095438/
Stenkamp-Strahm C, Melody B, Brinson P et al. A longitudinal study of influenza A viral detection in bulk tank and pen-level milk collected from dairy farms in California affected by Highly Pathogenic Avian Influenza H5N1. J Dairy Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42092544/
Frederick JC, Lacek KA, Wersebe MJ et al. Next-Generation Sequencing Strategies During the 2024-2025 Avian Influenza A(H5N1) Emergency Response in the U.S. Viruses. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42043271/
Mohammad I, Hajelbashir MI, El-Bidawy MH et al. Deciphering HPAI Influenza A Virus (H5N1): Molecular Basis of Pathogenicity, Zoonotic Potential, and Advances in Vaccination Strategies. Viruses. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42043199/
European Food Safety Authority (EFSA), European Centre for Disease Prevention and Control (ECDC), European Union Reference Laboratory for Avian Influenza (EURL) et al. Avian influenza overview December 2025-February 2026. EFSA J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42016297/
Wiggins J, Madapong A, Weaver EA. Dual-route H5N1 vaccination induces systemic and mucosal immunity in murine and bovine models. NPJ Vaccines. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42014782/